Randolph Company’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Randolph Company’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-125	Closed	-$3K	–	41
2019 Q3	$3K	Hold	125	–	–	﹤0.01%	38
2019 Q2	$4K	Hold	125	–	–	﹤0.01%	46
2019 Q1	$11K	Hold	125	–	–	﹤0.01%	39
2018 Q4	$8K	Hold	125	–	–	﹤0.01%	28
2018 Q3	$13K	Buy	+125	New	+$12.7K	﹤0.01%	41

Other funds holding NURO

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RIA

Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Randolph Company's NURO Position: Q4 2019 in Review

Randolph Company sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2019, closing a stake of 125 shares — an estimated $3K sold.

Randolph Company first reported a position in NURO in Q3 2018 and held it in 5 quarters. The position peaked at $13K in Q3 2018. 8 funds tracked by Wall St. Rank hold NURO as of Q4 2019.

Randolph Company reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Randolph Company sold 125 NeuroMetrix, Inc. Common Stock shares in Q4 2019, an estimated $3K.
Randolph Company first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Randolph Company's NeuroMetrix, Inc. Common Stock position peaked at $13K in Q3 2018.
8 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2019.

Based on Randolph Company's 13F filing for Q4 2019, filed 27 Jan 2020.